Gladwyn Financial Advisors Inc. Buys Shares of 465 GE HealthCare Technologies Inc. $GEHC

Gladwyn Financial Advisors Inc. bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 465 shares of the company’s stock, valued at approximately $34,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. N.E.W. Advisory Services LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at about $25,000. Bogart Wealth LLC boosted its stake in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its stake in GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after acquiring an additional 222 shares during the last quarter. Olde Wealth Management LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at about $35,000. Finally, Game Plan Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $74.05 on Friday. The firm’s 50 day simple moving average is $74.51 and its 200 day simple moving average is $72.03. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $33.81 billion, a PE ratio of 15.17, a price-to-earnings-growth ratio of 2.83 and a beta of 1.13. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is 2.87%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GEHC. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. BTIG Research upped their price target on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Barclays started coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target on the stock. Finally, Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.